Jeonbuk National University Hospital

Jeonju-si, Jeollabuk-do 54907

0 studies enrolling now · 2 studies all time

What they study most

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

Studies at this site

• Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. — Stopped early
• Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression — Completed